Oxidant-induced cardiomyocyte injury

Identification of the cytoprotective effect of a dopamine 1 receptor agonist using a cell-based high-throughput assay

Domokos Gerö, Katalin Modis, Nóra Nagy, Petra Szoleczky, Zoltán Dóri Tóth, György Dormán, Csaba Szabo

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Myocyte injury due to myocardial reperfusion injury plays a crucial role in the pathogenesis of acute myocardial infarction even after successful coronary revascularization. Identification of compounds that reduce reperfusion- associated myocyte death is important. Therefore, we developed an in vitro model of myocardial reperfusion injury in H9c2 rat cardiomyocytes and applied a cell-based high-throughput approach to screen a standard library of pharmacologically active compounds (LOPAC) in order to identify drugs with cardioprotective effects. Oxidative stress was induced with hydrogen peroxide (H2O2) treatment, which resulted in ∼50% reduction in cell viability. Test compounds were added at a 3-μM final concentration as a pretreatment or in a delayed fashion (30 min after the peroxide challenge in order to imitate pharmacological treatment following angioplasty). Cells were cultured for 3 or 24 h. Viability was quantitated with the methylthiazolyldiphenyl-tetrazolium bromide method. Cytotoxicity and cytoprotection were also evaluated by measuring the lactate dehydrogenase activity in the cell culture supernatant. The screening identified a number of compounds with cytoprotective action, including molecules that are known to interfere with components of DNA repair and cell cycle progression, e.g. poly(ADP-ribose) polymerase (PARP) inhibitors, topoisomerase inhibitors, and cyclin dependent kinase inhibitors, or reduce energy consumption by interfering with cardiac myofilament function. A number of dopamine D1 receptor agonists also provided significant cytoprotection at 3 h, but only three of them showed a similar effect at 24 h: chloro- and bromo-APB and chloro-PB hydrobromide. Chloro-APB hydrobromide significantly reduced peroxide-induced PARP activation in the myocytes independently of its action on dopamine D1 receptors, but lacked PARP inhibitor capacity in a cell-free PARP assay system. In conclusion, the pattern of cytoprotective drugs identified in the current assay supports the overall validity of our model system. The findings demonstrate that cytoprotective agents, including novel indirect inhibitors of cellular PARP activation can be identified with the method, chloro-APB hydrobromide being one such compound. The current experimental setting can be employed for cell-based high-throughput screening of various compound libraries.

Original languageEnglish (US)
Pages (from-to)749-761
Number of pages13
JournalInternational Journal of Molecular Medicine
Volume20
Issue number5
StatePublished - Nov 2007
Externally publishedYes

Fingerprint

Dopamine Agonists
Cardiac Myocytes
Oxidants
Muscle Cells
Myocardial Reperfusion Injury
Dopamine D1 Receptors
Cytoprotection
Poly(ADP-ribose) Polymerases
Peroxides
Wounds and Injuries
Topoisomerase Inhibitors
Cyclin-Dependent Kinases
Myofibrils
Bromides
Angioplasty
L-Lactate Dehydrogenase
DNA Repair
Pharmaceutical Preparations
Hydrogen Peroxide
Libraries

Keywords

  • Apoptosis
  • Cell necrosis
  • High content screening
  • High-throughput screening
  • Myocardial infarction
  • Oxidative stress
  • Poly(ADP-ribose) polymerase

ASJC Scopus subject areas

  • Genetics

Cite this

Oxidant-induced cardiomyocyte injury : Identification of the cytoprotective effect of a dopamine 1 receptor agonist using a cell-based high-throughput assay. / Gerö, Domokos; Modis, Katalin; Nagy, Nóra; Szoleczky, Petra; Tóth, Zoltán Dóri; Dormán, György; Szabo, Csaba.

In: International Journal of Molecular Medicine, Vol. 20, No. 5, 11.2007, p. 749-761.

Research output: Contribution to journalArticle

@article{e947743c218843978f30ef0fa95a9ee5,
title = "Oxidant-induced cardiomyocyte injury: Identification of the cytoprotective effect of a dopamine 1 receptor agonist using a cell-based high-throughput assay",
abstract = "Myocyte injury due to myocardial reperfusion injury plays a crucial role in the pathogenesis of acute myocardial infarction even after successful coronary revascularization. Identification of compounds that reduce reperfusion- associated myocyte death is important. Therefore, we developed an in vitro model of myocardial reperfusion injury in H9c2 rat cardiomyocytes and applied a cell-based high-throughput approach to screen a standard library of pharmacologically active compounds (LOPAC) in order to identify drugs with cardioprotective effects. Oxidative stress was induced with hydrogen peroxide (H2O2) treatment, which resulted in ∼50{\%} reduction in cell viability. Test compounds were added at a 3-μM final concentration as a pretreatment or in a delayed fashion (30 min after the peroxide challenge in order to imitate pharmacological treatment following angioplasty). Cells were cultured for 3 or 24 h. Viability was quantitated with the methylthiazolyldiphenyl-tetrazolium bromide method. Cytotoxicity and cytoprotection were also evaluated by measuring the lactate dehydrogenase activity in the cell culture supernatant. The screening identified a number of compounds with cytoprotective action, including molecules that are known to interfere with components of DNA repair and cell cycle progression, e.g. poly(ADP-ribose) polymerase (PARP) inhibitors, topoisomerase inhibitors, and cyclin dependent kinase inhibitors, or reduce energy consumption by interfering with cardiac myofilament function. A number of dopamine D1 receptor agonists also provided significant cytoprotection at 3 h, but only three of them showed a similar effect at 24 h: chloro- and bromo-APB and chloro-PB hydrobromide. Chloro-APB hydrobromide significantly reduced peroxide-induced PARP activation in the myocytes independently of its action on dopamine D1 receptors, but lacked PARP inhibitor capacity in a cell-free PARP assay system. In conclusion, the pattern of cytoprotective drugs identified in the current assay supports the overall validity of our model system. The findings demonstrate that cytoprotective agents, including novel indirect inhibitors of cellular PARP activation can be identified with the method, chloro-APB hydrobromide being one such compound. The current experimental setting can be employed for cell-based high-throughput screening of various compound libraries.",
keywords = "Apoptosis, Cell necrosis, High content screening, High-throughput screening, Myocardial infarction, Oxidative stress, Poly(ADP-ribose) polymerase",
author = "Domokos Ger{\"o} and Katalin Modis and N{\'o}ra Nagy and Petra Szoleczky and T{\'o}th, {Zolt{\'a}n D{\'o}ri} and Gy{\"o}rgy Dorm{\'a}n and Csaba Szabo",
year = "2007",
month = "11",
language = "English (US)",
volume = "20",
pages = "749--761",
journal = "International Journal of Molecular Medicine",
issn = "1107-3756",
publisher = "Spandidos Publications",
number = "5",

}

TY - JOUR

T1 - Oxidant-induced cardiomyocyte injury

T2 - Identification of the cytoprotective effect of a dopamine 1 receptor agonist using a cell-based high-throughput assay

AU - Gerö, Domokos

AU - Modis, Katalin

AU - Nagy, Nóra

AU - Szoleczky, Petra

AU - Tóth, Zoltán Dóri

AU - Dormán, György

AU - Szabo, Csaba

PY - 2007/11

Y1 - 2007/11

N2 - Myocyte injury due to myocardial reperfusion injury plays a crucial role in the pathogenesis of acute myocardial infarction even after successful coronary revascularization. Identification of compounds that reduce reperfusion- associated myocyte death is important. Therefore, we developed an in vitro model of myocardial reperfusion injury in H9c2 rat cardiomyocytes and applied a cell-based high-throughput approach to screen a standard library of pharmacologically active compounds (LOPAC) in order to identify drugs with cardioprotective effects. Oxidative stress was induced with hydrogen peroxide (H2O2) treatment, which resulted in ∼50% reduction in cell viability. Test compounds were added at a 3-μM final concentration as a pretreatment or in a delayed fashion (30 min after the peroxide challenge in order to imitate pharmacological treatment following angioplasty). Cells were cultured for 3 or 24 h. Viability was quantitated with the methylthiazolyldiphenyl-tetrazolium bromide method. Cytotoxicity and cytoprotection were also evaluated by measuring the lactate dehydrogenase activity in the cell culture supernatant. The screening identified a number of compounds with cytoprotective action, including molecules that are known to interfere with components of DNA repair and cell cycle progression, e.g. poly(ADP-ribose) polymerase (PARP) inhibitors, topoisomerase inhibitors, and cyclin dependent kinase inhibitors, or reduce energy consumption by interfering with cardiac myofilament function. A number of dopamine D1 receptor agonists also provided significant cytoprotection at 3 h, but only three of them showed a similar effect at 24 h: chloro- and bromo-APB and chloro-PB hydrobromide. Chloro-APB hydrobromide significantly reduced peroxide-induced PARP activation in the myocytes independently of its action on dopamine D1 receptors, but lacked PARP inhibitor capacity in a cell-free PARP assay system. In conclusion, the pattern of cytoprotective drugs identified in the current assay supports the overall validity of our model system. The findings demonstrate that cytoprotective agents, including novel indirect inhibitors of cellular PARP activation can be identified with the method, chloro-APB hydrobromide being one such compound. The current experimental setting can be employed for cell-based high-throughput screening of various compound libraries.

AB - Myocyte injury due to myocardial reperfusion injury plays a crucial role in the pathogenesis of acute myocardial infarction even after successful coronary revascularization. Identification of compounds that reduce reperfusion- associated myocyte death is important. Therefore, we developed an in vitro model of myocardial reperfusion injury in H9c2 rat cardiomyocytes and applied a cell-based high-throughput approach to screen a standard library of pharmacologically active compounds (LOPAC) in order to identify drugs with cardioprotective effects. Oxidative stress was induced with hydrogen peroxide (H2O2) treatment, which resulted in ∼50% reduction in cell viability. Test compounds were added at a 3-μM final concentration as a pretreatment or in a delayed fashion (30 min after the peroxide challenge in order to imitate pharmacological treatment following angioplasty). Cells were cultured for 3 or 24 h. Viability was quantitated with the methylthiazolyldiphenyl-tetrazolium bromide method. Cytotoxicity and cytoprotection were also evaluated by measuring the lactate dehydrogenase activity in the cell culture supernatant. The screening identified a number of compounds with cytoprotective action, including molecules that are known to interfere with components of DNA repair and cell cycle progression, e.g. poly(ADP-ribose) polymerase (PARP) inhibitors, topoisomerase inhibitors, and cyclin dependent kinase inhibitors, or reduce energy consumption by interfering with cardiac myofilament function. A number of dopamine D1 receptor agonists also provided significant cytoprotection at 3 h, but only three of them showed a similar effect at 24 h: chloro- and bromo-APB and chloro-PB hydrobromide. Chloro-APB hydrobromide significantly reduced peroxide-induced PARP activation in the myocytes independently of its action on dopamine D1 receptors, but lacked PARP inhibitor capacity in a cell-free PARP assay system. In conclusion, the pattern of cytoprotective drugs identified in the current assay supports the overall validity of our model system. The findings demonstrate that cytoprotective agents, including novel indirect inhibitors of cellular PARP activation can be identified with the method, chloro-APB hydrobromide being one such compound. The current experimental setting can be employed for cell-based high-throughput screening of various compound libraries.

KW - Apoptosis

KW - Cell necrosis

KW - High content screening

KW - High-throughput screening

KW - Myocardial infarction

KW - Oxidative stress

KW - Poly(ADP-ribose) polymerase

UR - http://www.scopus.com/inward/record.url?scp=38449115536&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38449115536&partnerID=8YFLogxK

M3 - Article

VL - 20

SP - 749

EP - 761

JO - International Journal of Molecular Medicine

JF - International Journal of Molecular Medicine

SN - 1107-3756

IS - 5

ER -